Global (United States, European Union and China) Deferasirox Market Research Report 2019-2025 (Includes Business Impact of COVID-19)

  • TBI862405
  • September 18, 2019
  • Global
  • 139 pages
  • TSCIR
                                          

Abstract, Snapshot, Market Analysis & Market Definition: World Deferasirox Market

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood.                    Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service. In 2019, the market size of Deferasirox is 2373.6 million US$ and it will reach 3234.5 million US$ in 2025, growing at a CAGR of 4.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Deferasirox. This report studies the global market size of Deferasirox, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India, and Southeast Asia). This study presents the Deferasirox sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019

Market Segmentation, Outlook & Viewpoint: World Deferasirox Market

Segmentation by Product Type: Breakdown of data from the year 2014 to 2019 and forecast until 2025: 500 mg/Tablet 250 mg/Tablet 125 mg/Tablet Others Segmentation by Application: Breakdown of data from the year 2014 to 2019 and forecast until 2025: Transfusional Iron Overload NTDT Caused Iron Overload

Top Companies & Key Players: World Deferasirox Market

Novartis Cipla Sun Pharma Natco Pharma

Key Insights Covered: World Deferasirox Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue, and growth rate) of Deferasirox industry. 2. Global major manufacturers' operating situation (sales, revenue, growth rate, and gross margin) of Deferasirox industry. 3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue, and growth rate) of Deferasirox industry. 4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Deferasirox industry. 5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Deferasirox industry.

Research Methodology: Global Deferasirox Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.

 1 Report Overview    1.1 Study Scope    1.2 Major Manufacturers Covered in This Report    1.3 Market Segment by Type
1.3.1 Global Deferasirox Market Size Growth Rate by Type (2019-2025)
1.3.2 500 mg/Tablet
1.3.3 250 mg/Tablet
1.3.4 125 mg/Tablet
1.3.5 Others    1.4   
1.4.1 Global Deferasirox Market Share by Application (2019-2025)
1.4.2 Transfusional Iron Overload
1.4.2 NTDT Caused Iron Overload    1.5 Study Objectives    1.6 Years Considered2 Global Growth Trends    2.1 Global Deferasirox Mar
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form